Tigecycline for complicated intra abdominal infections in surgical intensive care units
10.3760/cma.j.issn.1007-631X.2015.10.012
- VernacularTitle:替加环素治疗外科ICU难治性腹腔感染的临床疗效
- Author:
Zhiyi JIANG
;
Minying CHEN
;
Ning LIU
;
Song GUO
;
Juan CHEN
;
Bin OUYANG
;
Xiangdong GUAN
- Publication Type:Journal Article
- Keywords:
Bacterial infections;
Surgical procedures,operative;
Intensive care units;
Tigecycline
- From:
Chinese Journal of General Surgery
2015;30(10):785-788
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze clinical effectiveness of tigecycline for complicated intra abdominal infections (cIAIs) in surgical intensive care units.Methods The clinical data of patients diagnosed as cIAIs from Nov 2011 to Aug 2014 were retrospectively collected.Data of sex, age, severity of disease, bacterial strains and drug resistance, prior antibiotics, dosage of tigecycline were included.Results 1 862 patients were admitted into surgical intensive care unit from Nov 2011 to Aug 2014.54 patients were finally treated by tigecycline among 304 patients diagnosed as cIAIs.Acinetobacter baumannii (23.1％), Klebiella pneumonia (18.5％), Escherichia coli (16.9％) were the top three pathogenic bacteria.41/50 were of multiple bacterial infection.Previously adopted antibiotics were miscellaneous, the number of used antibiotics was up to 13 for one patient.Coverage of tigecycline averaged at 8.9 days.Tigecycline effective rate was 62％, 38％ (19/50) cIAIs were completely controlled and cured,24％ (12/50) patients showed effectiveness of tigercycline that procalcitonin decreased 50％ within 72 h.Logistic regression analysis showed that severity of disease and tigecycline dose contribute to the effectiveness within 72 h.Conclusions Tigecycline is effective alterative for patients diagnosed as complicated intra abdominal infections in surgical intensive care units.
